Modeling retinal degeneration using patient-specific induced pluripotent stem cells.

Area of Science:

• Ophthalmology
• Genetics
• Stem Cell Biology

Background:

• Retinitis pigmentosa (RP) is a leading inherited cause of blindness, characterized by rod photoreceptor degeneration.
• Current research is limited by the lack of patient-specific human photoreceptor cells for disease modeling and drug discovery.

Purpose of the Study:

• To generate patient-specific induced pluripotent stem (iPS) cells from retinitis pigmentosa patients.
• To differentiate these iPS cells into functional rod photoreceptor cells for disease mechanism studies.

Main Methods:

• Fibroblast cells were collected from five RP patients with mutations in RP1, RP9, PRPH2, or RHO genes.
• Patient-specific iPS cells were generated using four reprogramming factors.
• iPS cells were differentiated into rod photoreceptor cells for analysis.

Main Results:

• Patient-derived rod cells displayed appropriate immunocytochemical and electrophysiological characteristics.
• A decrease in the number of patient-derived rod cells was observed in vitro.
• Cells showed markers of oxidative and endoplasmic reticulum stress, with varied responses to vitamin E.

Conclusions:

• Patient-derived rod cells successfully recapitulate the disease phenotype of retinitis pigmentosa.
• These cells exhibit cellular stress responses linked to specific genetic mutations.
• Patient-derived iPS cells provide a valuable platform for investigating RP pathogenesis and developing therapies.